Shire submits dry-eye drug for marketing approval
August 15, 2017Manufacturing and Production, Sales and Marketing Shire, biotech, drugs, pharma, pharmaceutical
Shire has announced that it has submitted its dry-eye drug, lifitegrast, for European marketing approval. The filing comes after it …
Gilead set to open $250m, 23-acre campus
August 15, 2017Manufacturing and Production Gilead, biotech, drugs, pharma, pharmaceutical
Gilead is set for the grand unveiling of its new facility in La Verne, Southern California, after several years of …
Regeneron abandons respiratory syncytial virus therapy after late-stage failure
August 15, 2017Manufacturing and Production, Research and Development RSV, Regeneron, pharma, pharmaceuticals, respiratory syncytial virus
Regeneron has announced that the failure of suptavumab, its experimental treatment for respiratory syncytial virus (RSV), in late-stage trials, the …
Mundipharma agrees $250m ‘smart chemotherapy’ deal
August 15, 2017Manufacturing and Production, Sales and Marketing CellAct, Mundipharma, biotech, drugs, pharma, pharmaceutical
A small biotech that has been working on developing one treatment for the last decade has finally seen the fruits …
MSD CEO sparks exodus from Trump’s manufacturing council over Charlottesville violence
August 15, 2017Manufacturing and Production MSD, Merck, Prsident's American Manufacturing Council, charlottesville, pharma, pharmaceuticals
In a shock move, MSD Chairman and Chief Executive Officer Kenneth Frazier (pictured) has announced that he is to resign …
Battling misinformation on the world’s biggest killer
August 14, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing cardiovascular disease, cholesterol, healthcare, heart disease, heart failure, medicine, pharma, pharmaceutical
Simon Williams, Head of Communications and Policy at Heart UK, discusses the threat posed by cholesterol in the development of …
NICE knocks back advanced kidney cancer drug duo
August 14, 2017Sales and Marketing Cancer, Kidney cancer, NICE, medicine, pharma, pharmaceutical
NICE has dished out a double judgement turning down two drugs for advanced renal cell carcinoma, a form of kidney …
Takeda strikes partnership to develop single-drug cancer combo immunotherapies
August 14, 2017Medical Communications, Research and Development, Sales and Marketing Cancer, Takeda, immunotherapy, medicine, pharma, pharmaceuticals
Japanese pharma giant Takeda has announced that it is to partner up with US-based Shattuck Labs in a collaboration to …
Over 1,000 currently active cancer trials spell trouble for patient recruitment
August 14, 2017Medical Communications, Research and Development, Sales and Marketing Cancer, drugs, life sciences, medicine, pharma, pharmaceutical
The number of active clinical trials in the cancer space has reached more than 1,000 and rising, outstripping the number …
‘Hugely disturbing’ rise in UK children with type 2 diabetes, report finds
August 14, 2017Medical Communications, Sales and Marketing childhood obesity, diabetes, healthcare, life sciences, obesity, pharma, pharmaceuticals
A report from the Royal College of Paediatrics and Child Health (RCPCH) has highlighted a “hugely disturbing” rise in cases …
FDA investigating intragastric obesity treatment linked to five deaths
August 14, 2017Medical Communications, Sales and Marketing life sciences, medicine, obesity, pharma, pharmaceutical
The FDA has launched an investigation after five deaths thought to be caused by an obesity treatment surgery in which …
Celgene opts not to acquire Sutro Biopharma for $1bn, reworks existing partnership
August 11, 2017Medical Communications, Sales and Marketing Celgene, Sutro Biopharma, biotech, healthcare, life sciences, medicine, pharma, pharmaceutical
Celgene has announced that it has chosen not to scoop up Sutro Biopharma, rejecting to take advantage of an option …
Early-stage study gives hope for rare and fatal neurodegenerative condition
August 11, 2017Medical Communications, Research and Development biotech, drugs, healthcare, life sciences, medicine, pharma, pharmaceutical
A team of researchers at Washington University School of Medicine (WUSM) in St Louis and the Eunice Kennedy Shriver National …
Ending the era of $100,000 cancer drugs
August 11, 2017Medical Communications, Research and Development Cancer, biotech, drugs, healthcare, immunotherapy, life sciences, medicine, pharma, pharmaceutical
Paul Workman, Chief Executive and President of the Institute of Cancer Research, examines the spiralling cost of cancer treatments and …
Top Ten most popular articles on Pharmafile.com this week
August 11, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing FDA, Merck, NICE, Parkinson's, biotech, diabetes, pharma, pharmaceutical, top ten
Another week, another busy week in pharma. The last seven days have seen some remarkable strides in the diabetes space, …
Heart failure mortality rates fall across England and Wales, national audit finds
August 11, 2017Medical Communications, Research and Development cardiovascular, heart, heart disease, life sciences, pharma, pharmaceutical
Great news in the cardiovascular space as results from the National Heart Failure Audit indicate that better treatment has led …
Continuous manufacturing: Upgrading the supply chain to meet rising demand
August 10, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing continuous manufacturing, life sciences, manufacturing, medicine, pharma, pharmaceutical
Pharmaceutical production has long been the object of scrutiny to ensure the highest levels of quality and safety are maintained. …
Japanese telecom giant injects $1.1bn into Swiss biotech in largest-ever investment of its kind
August 10, 2017Sales and Marketing Roivant, SoftBank, biotech, life sciences, medicine, pharma, pharmaceuticals
In possibly the biggest single biotech investment ever made, Swiss biotech firm Roivant has received a $1.1 billion cash injection …
Bayer’s liver cancer drug availability spreads to UK with NICE approval
August 10, 2017Sales and Marketing Bayer, Cancer, NICE, Nexavar, life sciences, liver cancer, pharma, pharmaceutical
NICE has announced that it has given final appraisal recommending Bayer’s Nexavar (sorafenib) for the treatment of advanced hepatocellular carcinoma …
One in twelve US doctors accepted opioid-related payments from pharma, finds study
August 10, 2017Medical Communications, Sales and Marketing US, bribe, drugs, life sciences, medicine, opioids, pharma, pharmaceutical
In the first large-scale study of its kind, a team of researchers at Boston Medical Center’s Grayken Center for Addiction …
Latest content
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
FibroFind appoints Professor Andrew Fisher as Chief Medical Officer
